Video

Expertise in Rare Tumor Surgery: What Sets Roswell Park Apart

At Roswell Park Comprehensive Cancer Center, rare tumors of the brain, spinal cord and neurons are treated with uncommon expertise.

News

Can a BiTE Immunotherapy Improve Survival in Young Patients with High-Risk Kinase-Driven B-ALL Subtypes?

Two genetic subtypes of childhood B-cell acute lymphoblastic leukemia (B-ALL) have long been associated with inferior treatment outcomes: Philadelphia chromosome-positive (Ph+) and ABL-class Philadelphia chromosome-like (Ph-like) B-ALL.

Video

Meet the Team: Eleanor Fallon, MD

Eleanor Fallon, MD, joined Roswell Park Comprehensive Cancer Center to combine her two passions: treating melanoma and non-melanoma skin cancers and research into how immunotherapy can be used to make other therapies more effective.

Video

New CAR T-Cell Therapy Shows Promise as ‘Magic Bullet’ for Patients with Relapsed/Refractory AML — Even After Transplant

A phase 1 clinical trial underway exclusively at Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., is evaluating a new chimeric antigen receptor (CAR) T-cell therapy that could dramatically transform the treatment of relapsed ...

Video

New Trial Tests Gabapentin As Treatment for Mucositis, Replacing Opioids

A new trial available at Roswell Park Comprehensive Cancer Center, organized by the Alliance for Clinical Trials in Oncology Foundation, is looking to determine the efficacy of using gabapentin for pain mitigation.

News

Can Prophylactic Radiation Prevent Complications of Bone Metastases in High-Risk, Asymptomatic Patients?

Some bone metastases appear to be at higher risk for such complications as pathologic fracture, spinal cord compression, pain or surgery to bone, even if they’re asymptomatic